PreveCeutical Medical Inc. PREV
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 55.43% | 25.84% | 637.02% | -153.05% | -231.76% |
| Total Depreciation and Amortization | 3.45% | 36.36% | 44.44% | 36.84% | 61.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -68.02% | -10.36% | -1,475.77% | 37.62% | 608.46% |
| Change in Net Operating Assets | 0.17% | -80.68% | 845.51% | 56.90% | -9.62% |
| Cash from Operations | 51.23% | -174.14% | -713.80% | -361.42% | -190.88% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | -2,000.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 460.00% | 39,700.00% | -1,700.00% |
| Total Debt Issued | 100.85% | -99.15% | -14.78% | -- | -137.76% |
| Total Debt Repaid | -- | -- | -4,880.00% | -2,970.00% | 6.53% |
| Issuance of Common Stock | -59.23% | 461.40% | 853.53% | 592.11% | 550.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.00% | 170.09% | 231.77% | 424.39% | 193.01% |
| Foreign Exchange rate Adjustments | 1,900.00% | 820.00% | 17,000.00% | -19,600.00% | 83.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,122.22% | 124.87% | -259.14% | -- | 52.63% |